logo
logo

Medhub Announces Completion Of Its Pivotal Multi-Center Validation Study And Raises $1 Million In New Financing

Feb 08, 2022•over 3 years ago

Amount Raised

$1 Million

Round Type

seed

Tel Aviv

Description

MedHub, a privately held medical device company focused on improving and simplifying cardiac care by replacing risky and costly invasive procedures with AI image-based tools, today announced that it has successfully secured $1 million bringing the total sum raised to $4.2 million. The round was led by Mr. Ron Zuckerman who was joined by new investor, Prof. Rafael Beyar.

Company Information

Company

Med Hub

Location

Tel Aviv, Tel Aviv District, Israel

About

MedHub MedHub provides the world's most efficient and user-friendly image-based FFR system, built on revolutionary AI technology. The MedHub AutocathFFRTM is commercially available and has already been implemented in 4 large hospitals. MedHub's vision is to streamline and improve cardiac catheterization procedures by eliminating costly, invasive supplementary procedures and replacing them with image-based software. Based in Tel Aviv, Israel